KohaneI. S., “The Incidentalome: A Threat to Genomic Medicine,”JAMA296, no. 2 (2006): 212–215; LanderE. S., “Initial Sequencing and Analysis of the Human Genome,”Nature409, no. 6822 (2001): 860–921.
2.
VenterJ. C., “The Sequence of the Human Genome,”Science291, no. 5507 (2001): 1304–1351.
3.
International Human Genome Consortium, “Finishing the Euchromatic Sequence of the Human Genome,”Nature431, no. 7011 (2004): 931–945.
4.
SugiyamaE., “Pharmacokinetics of Gemcitabine in Japanese Cancer Patients: The Impact of a Cytidine Deaminase Polymorphism,”Journal of Clinical Oncology25, no. 1 (2007): 32–42.
5.
WolfS. M., “Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations,”Journal of Law, Medicine & Ethics36, no. 2 (2008): 219–248.
6.
Centers for Medicare and Medicaid Services, “Clinical Laboratory Improvement Amendments,”available at <http://www.cms.hhs.gov/CLIA/> (last visited December 30, 2007).
7.
TurneyL., “The Incidental Discovery of Nonpaternity Through Genetic Carrier Screening: An Exploration of Lay Attitudes,”Qualitative Health Research15, no. 5 (2005): 620–634.
8.
Unpublished observation of author (November 11, 2007).
9.
ShalowitzD. I.MillerF. G., “Disclosing Individual Results of Clinical Research: Implications of Respect for Participants,”JAMA294, no. 6 (2005): 737–740.
10.
See Kohane, supra note 1.
11.
KnoppersB. M., “The Emergence of an Ethical Duty to Disclose Genetic Research Results: International Perspectives,”European Journal of Human Genetics14, no. 10 (2006): 1170–1178.
12.
National Heart, Lung & Blood Institute (NHLBI), NHLBI Working Group on Reporting Genetic Results in Research Studies, Bethesda, MD, 2004, available at <http://www.nhlbi.nih.gov/meetings/workshops/gene-results.htm> (last visited November 11, 2007).
13.
Id.
14.
Council for International Organization of Medical Sciences (CIOMS), International Guidelines for Biomedical Research Involving Human Subjects, Geneva, 2002, available at <http://www.cioms.ch/frame_guidelines-nov_2002.htm> (last visited November 11, 2007).
Consortium on Pharmacogenetics, Ethical and Regulatory Issues in Research and Clinical Practice, Minneapolis, 2002, available at <http://www.bioethics.umn.edu/News/pharm_report.pdf> (last visited November 11, 2007).
Canadian College of Medical Geneticists, “Policy Statement Concerning DNA Banking and Molecular Diagnosis,”Clinical Investigation of Medicine14 (1991): 363–365.